Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"

Last updated: December 1, 2021
Sponsor: Autonomous Non-Profit Organization National Society of Onco-Pulmonologists
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05157503
4
  • Ages 18-80
  • All Genders

Study Summary

In connection with the transition to the 8th version of the classification of lung cancer according to the TNM system, there are currently no precise epidemiological data on stage III NSCLC, clinical characteristics of patients in this group, approaches to therapy and treatment results in the Russian Federation. The published statistics only provide information on the overall incidence of stage III lung, trachea and bronchial cancer, which is about 40%. This observational study will make it possible to characterize the Russian population of stage III non-small cell lung cancer patients, approaches to choosing a treatment option for stage III NSCLC and the outcomes of this treatment in real clinical practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • stage III non-small cell lung cancer

Exclusion

Exclusion Criteria:

  • the rest of the disease stage

Study Design

Total Participants: 1
Study Start date:
January 10, 2020
Estimated Completion Date:
March 31, 2023

Connect with a study center

  • National Medical Research Center of Oncology. N. N. Blokhin

    Moscow, 115478
    Russian Federation

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.